drugset / Trial / NCT02459977
The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Basiliximab has been a routine induction therapeutic agent even for well-matched living kidney transplantation(KT) with tacrolimus-based immunosuppression in Korea. As tacrolimus is a different drug from cyclosporine, the investigators study the usefulness of tacrolimus-based immunosuppression without basiliximab in well matched living KT.
Timeline
- Start
- 2012-04
- Primary completion
- 2015-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Basiliximab | Monoclonal antibody | — | — |
Indications
No indication recorded.